Jinfa Labi Maternity & Baby Articles Co (002762) Fair Value & Analysis
Consumer Cyclical · CN · Market cap 3.1B CNY
Fair value as of: Jun 25, 2026
Analysis
Jinfa Labi Maternity & Baby Articles Co (002762) currently trades at ¥8.43, while our model-based Fair Value estimate is ¥7.55 — implying the stock looks roughly 10.4% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Jinfa Labi Maternity & Baby Articles Co., Ltd engages in the design, research and development, production, and sale of maternal and infant consumer products in China. It offers infant and child clothing; infant cotton products, including baby underwear, baby household cotton products, and other cotton products; and other maternal and child daily necessities, such as maternal and child washing and care, feeding, bathroom, bedding, disinfection and hygiene, strollers and maternal, and infant products under the LABI BABY, I LOVE BABY, and BABY LABI brands. The company sells its products through offline franchise and direct stores, shopping mall counters, shopping center stores, brand stores, e-commerce platforms, live broadcast platforms, and online cloud stores. Jinfa Labi Maternity & Baby Articles Co., Ltd was founded in 1996 and is headquartered in Shantou, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Jinfa Labi Maternity & Baby Articles Co (002762) undervalued?
What is the fair value of 002762?
What is the quality score of 002762?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.